Newsletter
Health News

Ibogaine: A Promising Treatment for PTSD and TBI in Veterans

Ibogaine: A Promising Treatment for PTSD and TBI in Veterans
Written by PsychePen

The results were immediate and significant, showing improvements in PTSD, depression, anxiety, and overall functioning.

Summary: A recent study has shown that a single dose of the psychedelic drug ibogaine can significantly reduce depression and PTSD symptoms in US military veterans with traumatic brain injury (TBI). The study, conducted on 30 male veterans, also noted improvements in physical and social functioning, cognition, and mood.

Ibogaine: A New Hope for Veterans with PTSD and Traumatic Brain Injury

The study, led by researchers from Stanford Medicine, explored the effects of ibogaine, a compound found in the African shrub iboga, on veterans with TBI. Ibogaine is known for enhancing neuroplasticity, the brain’s ability to rewire itself. Despite being classified as a Schedule I drug in the United States, ibogaine treatments are available in clinics in Canada and Mexico.

The research involved 30 US special forces veterans with a history of TBI and repeated blast exposures. They were treated with ibogaine combined with magnesium, which protects the heart. The results were immediate and significant, showing improvements in PTSD, depression, anxiety, and overall functioning. These effects lasted for at least a month post-treatment. Cognitive testing also revealed enhancements in concentration, information processing, memory, and impulsivity control.

This study is groundbreaking as it provides evidence for a single treatment that can improve chronic disability related to repeated TBI from combat exposures. The treatment led to immediate and significant improvements in various psychiatric symptoms and disabilities, sustained for at least a month.

However, the study’s lack of a control group is a notable limitation, making it challenging to attribute the observed effects solely to ibogaine. Further research with larger sample sizes and control groups is needed to confirm these findings and fully understand ibogaine’s potential in treating TBI and PTSD.

Why It Matters: This study is significant as it adds to the growing evidence supporting the use of psychedelic substances in mental health treatment. The findings suggest that ibogaine could be a potent treatment for veterans suffering from PTSD and TBI, conditions that are often challenging to treat with conventional methods.

Potential Implications: If further research supports these findings, ibogaine could revolutionize the treatment of PTSD and TBI, particularly among veterans. This could lead to changes in drug policies and open new avenues for treating various mental health disorders with psychedelic substances.

Source: Medriva


Subscribe to our weekly newsletter:

We hope you enjoyed this news update. Check back with us daily to see what’s going on in the world of cannabis and psychedelics. And make sure to subscribe to our weekly newsletter, the Cannadelics Sunday Edition with a the best stories of the week:

.

.

AI Disclaimer: This news update was created using a AI tools. PsychePen is an AI author who is constantly improving. We appreciate your kindness and understanding as PsychePen continues to learn and develop. Please note that the provided information is derived from various sources and should not be considered as legal, financial, or medical advice.

Have anything to add? Your voice matters! Join the conversation and contribute your insights and ideas below.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

1 Comment

About the author

PsychePen

PsychePen is Cannadelics' main news editor. As a self-taught wellness expert with a unique perspective on drugs, cannabis, and psychedelics, PsychePen is known for his unique style: short and informative articles, easy-to-read and to-the-point. PsychePen is also one of our most successful AI authors. so its keep on improving.